Establishing a Better Microbiome for Better Health - Seres Therapeutics
Our mission is to transform the lives of patients worldwide with revolutionary microbiome therapeutics. Discover our progress.
Stats
Alexa Rank:
Popular in Country:
Country Alexa Rank:
language: en
Response Time: 0.875377
SSL: Disable
Status: up
Code To Txt Ratio
Word Count 81
Links
ratio 7.0328321571034
Found 77 Top Alternative to Serestherapeutics.com
Voyagertherapeutics.com
Voyager Therapeutics
Unlocking breakthroughs in AAV gene therapy and developing best-in-class treatments for CNS and other diseases.
104.154.252.57
United States
InValid
SSL
Amicusrx.com
Amicus Therapeutics | Advancing Therapies to Treat Rare Diseases
Amicus Therapeutics) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering high-quality medicines for people living with rare metabolic diseases.
G1therapeutics.com
G1 Therapeutics, Inc. | Optimizing Chemotherapy, Advancing Survival
G1 Therapeutics, Inc. is a commercial stage oncology company focused on the development and commercialization of next generation therapies that improve the lives of those affected by cancer.
Onconova.com
Onconova Therapeutics, Inc. - A Biopharmaceutical Company
Onconova Therapeutics, Inc. is focused on discovering and developing novel small molecule drug candidates to treat cancer.
Ovidrx.com
Impactful Medicines for Rare Neurological Disorders | Ovid Therapeutics
This is Ovid—where we are boldly transforming the lives of people affected by rare neurological diseases including Angelman syndrome, Fragile X syndrome and rare epilepsies.
Allogene.com
Home - Allogene
THE NEXT REVOLUTION IN CELL THERAPY Allogene is developing allogeneic chimeric antigen receptor T cell (AlloCAR T™) products to find the next immunologic breakthrough in cancer. That’s how we’re leading today, creating tomorrow. LEARN ABOUT AlloCAR T™ THE NEXT REVOLUTION IN CELL THERAPY Allogene is developing allogeneic chimeric antigen receptor T...
Rubiustx.com
Home - Rubius Therapeutics
Rubius Therapeutics | Red Cell Therapeutics™️ | Home Rubius Therapeutics is realizing the power of red by creating red blood cells and transforming them into cellular medicines. Learn More.
Cidara.com
Leading the Science of Protection - Cidara Therapeutics
Cidara is developing long-acting therapeutics designed to save lives and improve the standard of care for patients facing serious diseases. Antifungal: REZAFUNGIN A next-generation once-weekly echinocandin being developed for both the treatment and prevention of serious fungal infections Cloudbreak® Drug-Fc Conjugates Highly potent, long-acting, drug-Fc conjugates (DFCs) designed to inhibit...
Aclaristx.com
Home | Aclaris Therapeutics Inc.
Aclaris is a biopharmaceutical company that strives to translate scientific discoveries into everyday victories in dermatology, and beyond. Learn about our pipeline.
Sperotherapeutics.com
Developing MDR Bacterial Infection Treatments | Spero Therapeutics
Leading Product Candidates Spero Therapeutics is developing a portfolio of novel product candidates with the potential for meaningful patient impact and significant commercial applications. As a leader in the infectious disease field, we are highly committed to advancing new therapies for patients with serious infections. Our candidates are designed to...
Halozyme.com
Home | Halozyme
Halozyme has completed its acquisition of Antares Pharma, Inc., creating a leading drug delivery business. View details here. Inspiring New Inspiring New As of May 24, 2022, Halozyme completed its acquisition of Antares Pharma Inc., creating a leading drug delivery business with broadly licensable opportunities across the ENHANZE® and Antares’...
Akebia.com
Home - Akebia Therapeutics
Fully integrated renal biopharmaceutical company with a late stage product in global Phase 3 clinical development and a commercially available medicine.
Secondgenome.com
Second Genome
Discovering and developing transformational precision therapies Extending the definition of what constitutes human biology We go beyond human biology when searching for drug targets and therapies About Company Proprietary platform We've built a suite of proprietary tools and capabilities into our platform. These tools have allowed for increased efficiencies, mass...
Acorda.com
Acorda Therapeutics Biotechnology Company | MS and Spinal Cord Injury Treatments
Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis
Fatetherapeutics.com
Home - Fate Therapeutics
Privacy Overview This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you...
Bioxceltherapeutics.com
BioXcel Therapeutics Inc – BioXcel Therapeutics Inc
Innovative Medicine Backed by the Power of AI BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company developing transformative medicines in neuroscience and immuno-oncology utilizing artificial intelligence, or AI, approaches. Innovative Medicine Backed by the Power of AI BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company developing transformative medicines in neuroscience and...
Mirati.com
Mirati Therapeutics, Inc. | Relentless Focus on Innovation | Targeted Oncology
At Mirati, we are relentlessly focused on developing best-in-class targeted therapies to meaningfully impact the lives of patients with cancer.
Tgtherapeutics.com
TG Therapeutics
ABOUT US Our Story Message From Our CEO Leadership Team Board Members Guiding Principles Join Us OUR SCIENCE Our Approach Our Focus MZL/FL CLL MS Collaborate With Us Meet with TG Medical OUR PRODUCTS OUR PIPELINE Overview Umbralisib Ublituximab TG-1501 TG-1701 TG 1801 OUR PUBLICATIONS OUR TRIALS Trial Information Expanded...
Poseida.com
Home - Poseida Therapeutics
Poseida Therapeutics is a clinical-stage biopharmaceutical company leveraging its proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical needs.
Technologies Used by serestherapeutics.com
Dns Records of serestherapeutics.com
A Record: 35.188.165.14AAAA Record:
CNAME Record:
NS Record: ns66.worldnic.com ns65.worldnic.com
SOA Record: namehost.worldnic.com
MX Record: serestherapeutics-com.mail.protection.outlook.com
SRV Record:
TXT Record: CE77-B30B-0A13-215C-D8E7-AE1C-A7F2-256F apple-domain-verification=KNJhSjqToDC4kMZf docusign=ce38bec8-cd62-445b-a7f2-0450771216eb atlassian-domain-verification=7iV2f9poLhAqcxaJ7sqzRBEf0ikvmkKX9vi51LmWuOF4gGoaUSCVYMZ1K0w7g8Jq fspmld9roj299a4b59n1hvki43 v=spf1 ip4:52.22.22.121 ip4:12.47.172.13 ip4:12.47.172.14 include:_spf.google.com include:spf.protection.outlook.com -all MS=ms26078535 google-site-verification=f47_n5qU3I0syYqEdKOTLTYtbqAz6RMCpZvxzbqKP3Y atlassian-domain-verification=8ckn3EIELhyUeZSON5lVvrkI2q5UZY0RghM6vN7lwwTA0oxRFcg+AWfMZuqwSzwf
DNSKEY Record:
CAA Record:
Whois Detail of serestherapeutics.com
Domain Name: SERESTHERAPEUTICS.COMRegistry Domain ID: 1659734346_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-04-04T07:34:35Z
Creation Date: 2011-06-03T20:16:46Z
Registry Expiry Date: 2026-06-03T20:16:46Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS65.WORLDNIC.COM
Name Server: NS66.WORLDNIC.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2022-07-27T03:10:42Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.